(Q43801207)

26 November 2017

title

Biodistribution studies of 99mTc-labeled myoblasts in a murine model of muscular dystrophy (English)

1 reference

26 November 2017

0 references

1 reference

5

1 reference

26 November 2017

Colombo FR

1

1 reference

26 November 2017

Torrente Y

2

1 reference

26 November 2017

Casati R

3

1 reference

26 November 2017

Benti R

4

1 reference

26 November 2017

Salani S

6

1 reference

26 November 2017

D'Angelo MG

7

1 reference

26 November 2017

DeLiso A

8

1 reference

26 November 2017

Scarlato G

9

1 reference

26 November 2017

Bresolin N

10

1 reference

26 November 2017

Gerundini P

11

1 reference

26 November 2017

publication date

1 November 2001

1 reference

Nuclear Medicine and Biology

26 November 2017

published in

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

935-940

1 reference

Intra-aortic injection of myoblasts in mdx mice: genetic and technetium-99m cell labeling and biodistribution

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Muscle regeneration by bone marrow-derived myogenic progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

The fate of individual myoblasts after transplantation into muscles of DMD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Dystrophin expression in the mdx mouse restored by stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Myoblast transfer in the treatment of Duchenne's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Arterial delivery of myoblasts to skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Dystrophin protects the sarcolemma from stresses developed during muscle contraction

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

The in vitro cultivation and differentiation capacities of myogenic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

The molecular basis of muscular dystrophy in the mdx mouse: a point mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900256-6

7 January 2021

10.1016/S0969-8051(01)00256-6

Identifiers

DOI

1 reference

26 November 2017

1 reference